MicroRNA signatures differentiate uterine cancer tumor subtypes

Gynecologic Oncology

Volumn 118, Issue 3, 2010, Pages 251-257

  Ratner, Elena S ^a   Tuck, David ^a   Richter, Christine ^a   Nallur, Sunitha ^a   Patel, Rajeshvari M ^a   Schultz, Vince ^a   Hui, Pei ^a   Schwartz, Peter E ^a   Rutherford, Thomas J ^a   Weidhaas, Joanne B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinosarcoma; Endometrial cancer; MicroRNAs; Uterine papillary serous carcinoma

Indexed keywords

MICRORNA;

ARTICLE; BENIGN TUMOR; CANCER CLASSIFICATION; CARCINOSARCOMA; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; EVALUATION; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UTERUS CANCER; UTERUS TUMOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CARCINOSARCOMA; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

EID: 77955554637     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.05.010     Document Type: Article

References (55)

1. American Cancer Society. Cancer facts and figures. In: Society AGAC; 2008.
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M.J. Thun Cancer statistics, 2008 Cancer J. Clin. 58 2 2008 Mar-Apr 71 96
3. P. Rose Endometrial Carcinoma NEJM 1996 Aug 640 649
4. J. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol. Oncol. 15 1983 10 17
5. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am. J. Surg. Pathol. 6 1982 93 108
6. M.L. Carcangiu, and J.T. Chambers Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma Gynecol. Oncol. 47 1992 298 305
7. B.A. Goff, D. Kato, and R.E. Schmidt Uterine papillary serous carcinoma: patterns of metastatic spread Gynecol. Oncol. 54 1994 264 268
8. V.M. Abeler, and K.E. Kjorstad Endometrial adenocarcinoma in Norway: a study of a total population Cancer 67 1991 3093 3103
9. W.M. Christopherson, R.C. Alberhasky, and P.J. Connelly Carcinoma of the endometrium. Papillary adenocarcinoma: a clinical pathological study, 46 patients Am. J. Clin. Pathol. 77 1982 534 540
10. W.M. Christopherson, P.F. Connelly, and R.C. Alberhasky Carcinoma of the endometrium. An analysis of prognosticators in patients with favorable subtypes and stage I disease Cancer 51 1983 1705 1709
11. E. Sartori, L. Bazzurini, A. Gadducci, F. Landoni, A. Lissoni, T. Maggino, P. Zola, and B. La Face Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study Gynecol. Oncol. 67 1 1997 Oct 70 75
12. A. Zelmanowicz, A. Hildesheim, and M. Sherman Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors Gynecol. Oncol. 69 1998 253 257
13. I. Gorai, T. Yanagibashi, and A. Taki Uterine carcinosarcoma is derived from a single stem cell: an in vitro study Int. J. Cancer 72 1997 821 827
14. W. McCluggage Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas Int. J. Gynecol. Cancer 12 2002 687 690
15. W. McCluggage Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J. Clin. Pathol. 55 2002 321 325
16. K. Ito, K. Watanabe, and S. Nasim Prognostic significance of p53 overexpression in endometrial cancer Cancer Res. 54 1994 4667 4670
17. M. Silverman, P. Roche, R. Kho, G. Keeney, H. Li, and K. Podratz Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma Gynecol. Oncol. 77 2000 1 7
18. A.L. Pisani, D.A. Barbuto, D. Chen, L. Ramos, L.D. Lagasse, and B.Y. Karlan HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma Obstet. Gynecol. 85 1995 729 734
19. H. Tashiro, M. Blazes, and R. Wu Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies Cancer Res. 57 1997 3935 3940
20. Y. Todo Analysis of p53, MDR-1, and GST-pi expression in endometrial carcinoma Hokkaido Igaku Zasshi 78 2003 117 127
21. A. Hirasawa, D. Aoki, and J. Inoue Unfavorable prognostic factors associated with high frequency of microsatellite instability and comparative genomic hybridization analysis in endometrial cancer Clin. Cancer Res. 9 2003 5675 5682
22. F. Cirisano, and B. Karlan The role of the HER-2/neu oncogene in gynecologic cancers J. Soc. Gynecol. Investig. 3 1996 99 105
23. T. Razorenova, E. Samsonova, K. Pozharisskii, and G. Razorenov Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma Vopr. Onkol. 53 2007 682 689
24. C. Simionescu, C. Georgescu, and C. Mǎrgǎritescu P53 and PCNA immunoexpression in endometrial carcinomas Rom. J. Morphol. Embryol. 47 2006 137 141
25. Y. Wu, J. Wang, H. Wang, and X. Yang Study on expression of Ki-67, early apoptotic protein M30 in endometrial carcinoma and their correlation with prognosis Zhonghua Bing Li Xue Za Zhi 32 2003 314 318
26. A. Berchuck, G. Rodriguez, and R.B. Kinney Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage disease Am. J. Obstet. Gynecol. 164 1991 15 21
27. J. Lu, G. Getz, and E. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
28. F.J. Slack, and J.B. Weidhaas MiRNAs as potential magic bullet in cancer Future Oncol. Perspect. 2006
29. http://www.r-project.org. R Development Core Team: A Language and Environment for Statistical Computing. 2003.
30. R. Gentleman, V. Carey, and D. Bates Bioconductor: open software development for computational biology and bioinformatics Genome Biol. 5 2004 R80
31. G.K. Smyth Linear models and empirical bayes methods for assessing Stat. Appl. Genet. Mol. Biol. 3 2004 Article3
32. Y.a.Y.H. Benjamini Controlling the false discovery rate-a practical and powerful approach to multiple testing J. R. Stat. Soc. B Methodol. 57 1995 289 300
33. S. Chiosea, E. Jelezcova, and U. Chandran Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma Am. J. Pathol. 169 2006 1812 1820
34. C. Jay, J. Nemunaitis, P. Chen, P. Fulgham, and A. Tong miRNA profiling for diagnosis and prognosis of human cancer DNA Cell Biol. 26 2007 293 300
35. L. Zhang, S. Volinia, and T. Bonome Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer Proc. Natl Acad. Sci. USA 105 2008 7004 7009
36. S. Yu, H. Chen, P. Yang, and J. Chen Unique MicroRNA signature and clinical outcome of cancers DNA Cell Biol. 26 2007 283 292
37. M. Ozen, C. Creighton, M. Ozdemir, and M. Ittmann Widespread deregulation of microRNA expression in human prostate cancer Oncogene 27 2008 1788 1793
38. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, and F. Petrocca Casalini P et al MicroRNA signatures in human ovarian cancer Cancer Res. 67 2007 8699 8707
39. S.-M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev. 22 2008 894 907
40. G. Wang, W. Mao, and S. Zheng MicroRNA-183 regulates Ezrin expression in lung cancer cells FEBS Lett. 582 2008 3663 3668
41. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, and P. Casalini MicroRNA signatures in human ovarian cancer Cancer Res. 67 2007 8699 8707
42. F. Gottardo, C.G. Liu, and M. Ferracin Micro-RNA profiling in kidney and bladder cancers Urol. Oncol. 5 2007 6387 6392
43. P. Gandellini, M. Folini, N. Longoni, M. Pennati, M. Binda, M. Colecchia, and R. Salvioni MiR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C{varepsilon} Cancer Res. 69 2009 2287 2295
44. A. Feber, L. Xi, and J.D. Luketich MicroRNA expression profiles of esophageal cancer J. Thorac. Cardiovasc. Surg. 135 2008 255 260
45. P. Gregory, A. Bert, E. Paterson, S. Barry, A. Tsykin, G. Farshid, M. Vadas, Y. Khew-Goodall, and G. Goodall The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 Nat. Cell Biol. 10 2008 593 601
46. M. Segura, D. Hanniford, S. Menendez, L. Reavie, X. Zou, S. Alvarez-Diaz, S. Zakrzewski, E. Blochin, and A. Rose Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor PNAS 106 6 2009 1814 1819
47. Wolfe A.L. Mavrakis KJ, E. Oricchio, T. Palomero, K. de Keersmaecker, K. McJunkin, J. Zuber, T. James, Leslie C.S. Khan AA, J.S. Parker, Tam W. Paddison PJ, A. Ferrando, and H.G. Wendel Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia Nat. Cell Biol. 2010 Feb 28
48. V. Olive, M. Bennett, J. Walker, C. Ma, I. Jiang, C. Cordon-Cardo, Q. Li, S. Lowe, G. Hannon, and L. He miR-19 is a key oncogenic component of mir-17-92 Genes Dev. 23 2009 December 15 2839 2849
49. S. Hang, Y. Jian-Rong, X. Teng, H. Jun, X. Li, Y. Yunfei, and Z. Shi-Mei MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity Cancer Res. 69 2009 1135 1142
50. N. Filigheddu, I. Gregnanin, P. Porporato, D. Surico, B. Perego, L. Galli, C. Patrignani, A. Graziani, and N. Surico Differential expression of MicroRNAs between eutopic and ectopic endometrium in ovarian endometriosis J. Biomed. Biotechnol. 2010
51. S. Veerla, D. Lindgren, A. Kvist, A. Frigyesi, J. Staaf, H. Persson, and F. Liedberg ChebilG, Gudjonsson S, Borg A, Månsson W, Rovira C, Höglund M. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31 Int. J. Cancer 124 9 2009 May 1 2236 2242
52. H. Pass, C. Goparaju, S. Ivanov, J. Donington, M. Carbone, M. Hoshen, D. Cohen, A. Chajut, S. Rosenwald, H. Dan, S. Benjamin, and R. Aharonov Hsa-miR-29c is linked to the prognosis of malignant pleural mesothelioma Cancer Res. 70 2010 1916 1924
53. S. Landais, S. Landry, P. Legault, and E. Rassart Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia Cancer Res. 67 2007 5699 5707
54. Z. Hua, Q. Lv, W. Ye, C.K. Wong, and G. Cai MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia PLoS ONE 1 2006 e116
55. Z. Lei, B. Li, Z. Yang, H. Fang, and G.-M. Zhang Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration PLoS ONE 4 10 2009 e7629